We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Investor Sues Medtronic Over Alleged Infuse Scheme

Law360 (January 9, 2009, 12:00 AM EST) -- A shareholder of medical technology company Medtronic Inc. has filed a derivative suit alleging that the company’s directors and executives inflated the company’s earnings through a physician kickback scheme and other unlawful promotion of the off-label use of its Infuse Bone Graft product, which has been linked to serious health complications.

Richard M. Gulbrandsen filed the shareholder derivative complaint in Minnesota’s Fourth Judicial District Court, in Hennepin County, seeking compensatory and putative damages, among other penalties, and asking that the company’s board members be ousted for...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.